相似文献
1
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.
PLoS Biol. 2013 Nov;11(11):e1001699. doi: 10.1371/journal.pbio.1001699. Epub 2013 Nov 5.
2
Next-generation sequencing: big data meets high performance computing.
Drug Discov Today. 2017 Apr;22(4):712-717. doi: 10.1016/j.drudis.2017.01.014. Epub 2017 Feb 2.
3
1D Genome Sequencing on the Oxford Nanopore MinION.
Curr Protoc Hum Genet. 2017 Jul 11;94:18.11.1-18.11.14. doi: 10.1002/cphg.39.
4
The promise of nanopore technology: Nanopore DNA sequencing represents a fundamental change in the way that genomic information is read, with potentially big savings.
IEEE Pulse. 2014 Jul-Aug;5(4):52-4. doi: 10.1109/MPUL.2014.2321214.
5
A vision for ubiquitous sequencing.
Genome Res. 2015 Oct;25(10):1411-6. doi: 10.1101/gr.191692.115.
6
New grants to boost genome sequencing.
Cancer Discov. 2014 Oct;4(10):1110-1. doi: 10.1158/2159-8290.CD-NB2014-130. Epub 2014 Aug 28.
7
Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.
Clin Chem. 2016 Nov;62(11):1458-1464. doi: 10.1373/clinchem.2016.258632. Epub 2016 Sep 14.
8
The real cost of sequencing: higher than you think!
Genome Biol. 2011 Aug 25;12(8):125. doi: 10.1186/gb-2011-12-8-125.
9
Inexpensive multiplexed library preparation for megabase-sized genomes.
PLoS One. 2015 May 22;10(5):e0128036. doi: 10.1371/journal.pone.0128036. eCollection 2015.
10
Optimization of multiplexed RADseq libraries using low-cost adaptors.
Genetica. 2015 Apr;143(2):139-43. doi: 10.1007/s10709-015-9828-3. Epub 2015 Feb 11.
引用本文的文献
1
SNP and Haplotype Regional Heritability Mapping (SNHap-RHM): Joint Mapping of Common and Rare Variation Affecting Complex Traits.
Front Genet. 2022 Jan 6;12:791712. doi: 10.3389/fgene.2021.791712. eCollection 2021.
2
Genomics reveals the novel species placement of industrial contaminant isolates incorrectly identified as .
Microb Genom. 2021 Apr;7(4). doi: 10.1099/mgen.0.000564.
3
Utility of Genetic Testing from the Perspective of Parents/Caregivers: A Scoping Review.
Children (Basel). 2021 Mar 27;8(4):259. doi: 10.3390/children8040259.
4
Precision Population Medicine in Primary Care: The Sanford Chip Experience.
Front Genet. 2021 Mar 12;12:626845. doi: 10.3389/fgene.2021.626845. eCollection 2021.
5
Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting.
Eur J Health Econ. 2021 Aug;22(6):855-864. doi: 10.1007/s10198-021-01293-1. Epub 2021 Mar 25.
6
A scoping review of social and behavioral science research to translate genomic discoveries into population health impact.
Transl Behav Med. 2021 Apr 26;11(4):901-911. doi: 10.1093/tbm/ibaa076.
7
Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values.
Patient. 2021 Mar;14(2):187-196. doi: 10.1007/s40271-020-00448-1.
8
Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities.
Curr Genet Med Rep. 2019;7(2):63-74. doi: 10.1007/s40142-019-00162-x. Epub 2019 May 18.
9
Genome Diagnostics: Novel Strategies for Measuring Value.
J Manag Care Spec Pharm. 2019 Oct;25(10):1096-1101. doi: 10.18553/jmcp.2019.25.10.1096.
10
Cooperation between non-essential DNA polymerases contributes to genome stability in Saccharomyces cerevisiae.
DNA Repair (Amst). 2019 Apr;76:40-49. doi: 10.1016/j.dnarep.2019.02.004. Epub 2019 Feb 6.
本文引用的文献
1
Gene patenting--the Supreme Court finally speaks.
N Engl J Med. 2013 Aug 29;369(9):869-75. doi: 10.1056/NEJMhle1308199. Epub 2013 Jul 10.
2
After the revolution? Ethical and social challenges in 'personalized genomic medicine'.
Per Med. 2012 Jun 1;9(4):429-439. doi: 10.2217/pme.12.37.
3
Diagnostic cancer genome sequencing and the contribution of germline variants.
Science. 2013 Mar 29;339(6127):1559-62. doi: 10.1126/science.1233899.
4
Harm, hype and evidence: ELSI research and policy guidance.
Genome Med. 2013 Mar 26;5(3):21. doi: 10.1186/gm425. eCollection 2013.
5
We screen newborns, don't we?: realizing the promise of public health genomics.
Genet Med. 2013 May;15(5):332-4. doi: 10.1038/gim.2013.11. Epub 2013 Mar 7.
6
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer.
Ann Oncol. 2013 May;24(5):1238-44. doi: 10.1093/annonc/mds636. Epub 2013 Jan 9.
7
The next controversy in genetic testing: clinical data as trade secrets?
Eur J Hum Genet. 2013 Jun;21(6):585-8. doi: 10.1038/ejhg.2012.217. Epub 2012 Nov 14.
8
Evaluating genomic tests from bench to bedside: a practical framework.
BMC Med Inform Decis Mak. 2012 Oct 19;12:117. doi: 10.1186/1472-6947-12-117.
9
Exome and whole-genome sequencing as clinical tests: a transformative practice in molecular diagnostics.
Clin Chem. 2012 Nov;58(11):1507-9. doi: 10.1373/clinchem.2012.193128. Epub 2012 Oct 11.
10
Are research papers reporting results from nutrigenetics clinical research a potential source of biohype?
Account Res. 2012;19(5):285-307. doi: 10.1080/08989621.2012.718681.
Zotero 插件